Shortly after hysterectomy the patient was diagnosed with an ER/PR-negative breast cancer that showed overexpression of HER2/neu, but one year after hysterectomy no evidence for recurrence of uterine tumors, as e.g. peritoneal spreading, was obtained. The gene discussed is ERBB2; the disease is tumor of uterus.